Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Benjamin Dehay - Erwan Bezard

Terms

12Benjamin Dehay
13Erwan Bezard
3Miquel Vila

Associations

Freq.WeightAssociation
66Benjamin Dehay - Erwan Bezard
33Erwan Bezard - Miquel Vila
33Benjamin Dehay - Miquel Vila

Documents par ordre de pertinence
000000 (2015-09-08) Benjamin Dehay [France] ; Miquel Vila [Espagne] ; Erwan Bezard [France] ; Patrik Brundin [Suède] ; Jeffrey H. Kordower [États-Unis]Alpha-synuclein propagation: New insights from animal models.
000020 (2015) Benjamin Dehay [France] ; Miquel Vila [Espagne] ; Erwan Bezard [France] ; Patrik Brundin [États-Unis] ; Jeffrey H. Kordower [États-Unis]Alpha-synuclein propagation: New insights from animal models.
000070 (2013) Benjamin Dehay [France] ; Marta Martinez-Vicente ; Guy A. Caldwell ; Kim A. Caldwell ; Zhenyue Yue ; Mark R. Cookson ; Christine Klein ; Miquel Vila ; Erwan BezardLysosomal impairment in Parkinson's disease.
000039 (2014) Mathieu Bourdenx [France] ; Benjamin Dehay ; Erwan BezardDown-regulating α-synuclein for treating synucleopathies.
000138 (2011) Benjamin Dehay [France] ; Erwan BezardNew animal models of Parkinson's disease.
000160 (2011) Benjamin Dehay [France] ; Erwan Bezard [France]New animal models of Parkinson's disease
000038 (2014) Benjamin Dehay [France]Evidence piles Up for prion-like propagation mechanisms in synucleinopathies.
000043 (2014) Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. FacherisCombined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.
000060 (2013) Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo CartaStudy of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
000090 (2012) Benjamin Dehay [France]Single-molecule approach to find out toxic oligomeric alpha-synuclein species formation.
000093 (2012) Benjamin Dehay [France]New experimental approach for modeling Parkinson’s disease.
000105 (2012) Erwan Bezard [France] ; Zhenyu Yue [États-Unis] ; Deniz Kirik [Suède] ; Maria Grazia Spillantini [Royaume-Uni]Animal Models of Parkinson’s Disease: limits and relevance to neuroprotection studies
000135 (2012) Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; QIN LI [République populaire de Chine] ; Jonathan Brotchie [Canada] ; Erwan Bezard [République populaire de Chine, France]A Critique of Available Scales and Presentation of the Non-Human Primate Dyskinesia Rating Scale
000136 (2011) Benjamin Dehay [France]The true nature of α-synuclein unmasked!
000140 (2011) Benjamin Dehay [France]α‐synuclein, a prion‐like protein
000142 (2011) Benjamin Dehay [France]The true nature of α‐synuclein unmasked!
000181 (2011) Erwan Bezard [France] ; Serge Przedborski [États-Unis]A tale on animal models of Parkinson's disease
000450 (2003) Michael P. Hill [Royaume-Uni] ; Erwan Bezard [France] ; Steven G. Mcguire [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Ann Michel [Belgique] ; Renee Grimée [Belgique] ; Henrik Klitgaard [Belgique]Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L‐dopa and ropinirole in the MPTP‐lesioned marmoset
000519 (2000) Imad Ghorayeb [France] ; Pierre O. Fernagut [France] ; Incarnation Aubert [France] ; Erwan Bezard [France] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] ; François Tison [France]Toward a primate model of l‐dopa‐unresponsive parkinsonism mimicking striatonigral degeneration

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024